
Elmy Trio 40mg/5mg/12.5mg Tablet
Marketer
Jabs Biotech Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Elmy Trio 40mg/5mg/12.5mg Tablet
Trelmia Triple Action 40mg/5mg/12.5mg tablets combine three medications to effectively manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, significantly reducing the risk of future strokes and heart attacks. Trelmia Triple Action may be taken with or without food, at the same time each day. Dosage is individualized, and continued use as directed by your physician is crucial. The medication includes a diuretic, increasing urination; therefore, avoid ingestion within four hours of bedtime. Consistent use, even during periods of well-being, is essential for optimal therapeutic benefit, as hypertension often lacks noticeable symptoms. Discontinuing treatment elevates the risk of cardiovascular events. Commonly reported side effects comprise headache, dizziness, fatigue, altered taste perception, flu-like symptoms, diarrhea, and sinus inflammation. Report any persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to mitigate potential side effects such as muscle weakness, dry mouth, and excessive thirst. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney conditions, pregnancy, breastfeeding, or concurrent medication use, particularly those for hypertension or cardiac issues. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is recommended to ensure treatment efficacy and safety.
Primary Ingredients of Elmy Trio 40mg/5mg/12.5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Elmy Trio 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Elmy Trio 40mg/5mg/12.5mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Elmy Trio 40mg/5mg/12.5mg tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Elmy Trio 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Elmy Trio 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Elmy Trio 40mg/5mg/12.5mg tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, although consistent timing is recommended.
How Elmy Trio 40mg/5mg/12.5mg Tablet works:
Elmy Trio 40mg/5mg/12.5mg tablets contain telmisartan, amlodipine, and hydrochlorothiazide, which act synergistically to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both promote vasodilation, reducing blood pressure. Hydrochlorothiazide, a diuretic, enhances diuresis, eliminating excess fluid and electrolytes, and contributes to vasodilation and improved hemodynamic function.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Elmy Trio 40mg/5mg/12.5mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Use of Elmy Trio 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Concurrent breastfeeding and Elmy Trio 40mg/5mg/12.5mg tablet use is contraindicated due to potential infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Elmy Trio 40mg/5mg/12.5mg Tablets, due to potential side effects including dizziness, headache, nausea, or fatigue, which can impact concentration.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Elmy Trio 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. Elmy Trio 40mg/5mg/12.5mg tablets are generally not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Elmy Trio 40mg/5mg/12.5mg tablets, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Elmy Trio 40mg/5mg/12.5mg Tablet :
Should you forget to take your Elmy Trio 40mg/5mg/12.5mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Elmy Trio 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
